These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 8999421)
1. [Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites]. Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O Nuklearmedizin; 1996 Dec; 35(6):220-4. PubMed ID: 8999421 [TBL] [Abstract][Full Text] [Related]
2. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma. Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744 [TBL] [Abstract][Full Text] [Related]
3. [Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma]. Hervás Benito I; Rivas Sánchez A; Bello Arques P; Cañete A; Fernández JM; Saura Quiles A; González Cabezas P; Ruiz Rodríguez JC; Castell V; Pérez Pastor JL; Monfort JA; Mateo Navarro A Rev Esp Med Nucl; 2001 Aug; 20(5):369-76. PubMed ID: 11470071 [TBL] [Abstract][Full Text] [Related]
4. [Indications for MIBG scintigraphy in the diagnosis of neuroblastoma]. Hausegger KA; Fueger GF; Ebner F; Urban C Nuklearmedizin; 1989 Feb; 28(1):34-40. PubMed ID: 2710644 [TBL] [Abstract][Full Text] [Related]
5. [123I-MIBG scintigraphy in patients with neuroblastoma]. Koizumi M; Sawada H; Goto M; Iijima A; Watari T; Kurosawa H; Kurumada H; Sugita K; Furukawa T Kaku Igaku; 1994 May; 31(5):507-11. PubMed ID: 8028223 [TBL] [Abstract][Full Text] [Related]
7. [Results of scintigraphy with m-[123I]iodobenzylguanidine in neuroblastoma in children]. Ythier H; Marchandise X; Deveaux M; Venel H; Verney F; Mazingue F; Millot F Int J Rad Appl Instrum B; 1987; 14(2):107-12. PubMed ID: 3597111 [TBL] [Abstract][Full Text] [Related]
8. [Recurrence of a stage IV neuroblastoma]. Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O Nuklearmedizin; 1997 Jan; 36(1):32-5. PubMed ID: 9082339 [TBL] [Abstract][Full Text] [Related]
9. [Bone marrow metastases of neuroblastoma: MRT in comparison with bone marrow cytology and mIBG scintigraphy]. Benz-Bohm G; Gross-Fengels W; Widemann B; Linden A Rofo; 1990 May; 152(5):523-7. PubMed ID: 2160683 [TBL] [Abstract][Full Text] [Related]
10. [Scintigraphic diagnosis of neuroblastoma using meta-iodobenzylguanidine]. Kimmig B; Brandeis WE; Eisenhut M; Ludwig R; Adolph J Klin Padiatr; 1986; 198(3):224-9. PubMed ID: 3723986 [TBL] [Abstract][Full Text] [Related]
11. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?]. Sautter-Bihl ML; Bihl H; Heinze HG Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676 [TBL] [Abstract][Full Text] [Related]
12. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma. Shulkin BL; Shapiro B; Hutchinson RJ J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138 [TBL] [Abstract][Full Text] [Related]
13. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome. Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532 [TBL] [Abstract][Full Text] [Related]
14. [Iodine-123-MIBG scintigraphy in neuroblastoma; relationship between the intensity of uptake and tumor characteristics]. Okuyama C; Ushijima Y; Watanabe K; Sugihara H; Nishimura T Kaku Igaku; 1999 Oct; 36(8):827-34. PubMed ID: 10586543 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy. Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology. Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine. Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256 [TBL] [Abstract][Full Text] [Related]
18. Diffuse bone marrow uptake [123I]MIBG in neuroblastoma: an "MIBG super scan" case report. Giammarile F; Olier AL; Lumbroso J Q J Nucl Med; 1995 Jun; 39(2):119-21. PubMed ID: 8574805 [TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma]. Iwashita S; Nakajo M; Nakabeppu Y; Tanoue T; Yonekura R; Taguchi M; Shimabukuro K; Shinohara S; Sakata H Kaku Igaku; 1989 Sep; 26(9):1135-47. PubMed ID: 2810911 [TBL] [Abstract][Full Text] [Related]
20. The impact of 123I-meta-iodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma. Abrahamsen J; Lyck B; Helgestad J; Frederiksen PB Acta Oncol; 1995; 34(4):505-10. PubMed ID: 7605659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]